Related Experiment Video
Updated: Feb 2, 2026
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Intensive Versus Moderate Statin Therapy Discontinuation in Patients With Acute Ischemic Stroke or Transient Ischemic
Huai Wu Yuan1, Ren Jie Ji1, Ya Jie Lin1
1Department of Neurology, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Insights
Intensive statin therapy after stroke significantly increases early discontinuation risk by 273% compared to moderate therapy. This highlights a critical factor in secondary stroke prevention adherence.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Pharmacology
Background:
- Statin therapy is crucial for secondary prevention after ischemic stroke.
- The comparative discontinuation risk between intensive and moderate statin therapy remains unclear.
- Understanding discontinuation is vital for optimizing long-term treatment adherence and outcomes.
Purpose of the Study:
- To determine if intensive statin therapy significantly increases early discontinuation rates post-discharge.
- To compare the risk of statin discontinuation between intensive and moderate intensity regimens in stroke patients.
Main Methods:
- A multicenter registry study included 505 patients with ischemic stroke or transient ischemic attack prescribed statins.
- Statin intensity was classified per 2013 ACC/AHA guidelines.
- Logistic regression analysis assessed the association between statin intensity and discontinuation.
Main Results:
- Intensive statin therapy discontinuation rate was 31.3% versus 10.7% for moderate therapy (P < 0.001).
- Intensive statin therapy was associated with a 273% increased risk of discontinuation (OR=3.730; P < 0.001).
- This finding was consistent across most subgroups, with an exception for patients with NIH Stroke Scale scores ≥4.
Conclusions:
- Intensive statin therapy may significantly elevate the risk of early discontinuation in secondary stroke prevention.
- Future clinical trials should account for differential discontinuation rates between intensive and moderate statin therapies.
- Addressing discontinuation is essential for effective long-term stroke secondary prevention strategies.
Purpose:
The differences of discontinuation risk between intensive and mild-to-moderate statin therapy in patients with acute ischemic stroke is not clear. This study aimed to clarify whether intensive statin therapy resulted in a significant increase in discontinuation early after discharge.
Methods:
This multicenter registry study enrolled consecutive hospitalized patients with ischemic stroke or transient ischemic attack. All the patients were prescribed statin therapy at discharge. Intensity of statin therapy was defined according to the 2013 American College of Cardiology/American Heart Association guideline on the treatment of blood cholesterol. A logistic regression model was used to analyze the association between statin therapy intensity and discontinuation.
Findings:
This study included 505 patients, of whom 64 and 441 received intensive and moderate statin therapy, respectively (mean follow-up, approximately 6 months). The rates of discontinuation of intensive and moderate statin therapy were 31.3% and 10.7% (P < 0.001), respectively. Variables with significant differences between the intensive and moderate statin therapy groups were included in the adjusted logistic regression model. Intensive statin therapy significantly increased discontinuation risk by 273.0% (odds ratio = 3.730; 95% CI, 2.013-6.911; P < .001) compared with moderate statin therapy. The result was consistent in most subgroups, except for patients with National Institutes of Health Stroke Scale scores ≥4.
Implications:
In stroke secondary prevention, intensive statin therapy may significantly increase the risk of early discontinuation compared with moderate statin therapy. Future clinical trials that involve a comparison between intensive and moderate statin therapy for stroke secondary prevention should address the differences in discontinuation between these 2 groups.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:21Acid Attack on Concrete
The rate at which hydrogen...
01:29Sulfate Attack on Concrete
Sulfates from sources like soil, groundwater, or industrial effluents...
01:28Improper Integrals: Discontinuous Integrands
01:19Limits with Oscillating Discontinuities
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents